XBiotech Inc.
XBITNASDAQHealthcareBiotechnology
As of Oct 26, 2026 close
- Market cap
- $56.40M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.91$3.44
- Volume (live)
- -
- Avg. volume (3M)
- 58.99K
XBiotech (XBIT) Stock Price & Financial Analysis
XBiotech Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.82 - $1.93 |
|---|---|
| 52-Week High | $3.44 |
| 52-Week Low | $1.91 |
| Open | $1.92 |
| Volume (last close) | 136.29K |
| Average Volume (3M) | 58.99K |
| 50-Day MA | $2.22 |
|---|---|
| 200-Day MA | $2.35 |
| 1-Year Change | −19.92% |
| Market Cap | 56.40M |
|---|---|
| Shares Outstanding | 30.49M |
| Price to Book (P/B) | 0.44 |
| EV/EBITDA | 1.14 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Last Dividend Ex-Date | Jul 15, 2021 |
Source: Market prices and company fundamentals. Data as of Oct 26, 2026. Data sources and methodology
XBiotech at a Glance
As of the Oct 26, 2026 close, XBiotech (XBIT) has a market capitalization of $56.40M.
As of its latest reported balance sheet, it holds $109.53M in cash and securities against $0.00 of debt, a net cash position of $109.53M.
XBiotech does not currently pay a dividend.
The share price is down 19.9% over the past year. At $1.85 (the Oct 26, 2026 close) it sits near the bottom of its 52-week range of $1.91 to $3.44, below its 200-day moving average of $2.35.
Frequently Asked Questions About XBiotech
What is the current stock price for XBIT?
As of the Oct 26, 2026 close, XBIT stock trades at $1.85. The 52-week range is $1.91–$3.44, with a day range of $1.82–$1.93.
What is the P/E ratio for XBIT?
The P/E ratio (Price-to-Earnings) for XBIT is shown in the Key Statistics section. This valuation metric helps compare XBiotech Inc. to industry peers.
Does XBIT pay dividends?
XBiotech does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for XBIT?
Analyst ratings and recommendations for XBIT are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of XBIT?
As of the Oct 26, 2026 close, XBiotech's market capitalization is $56.4M, classifying it as a micro-cap company. XBiotech operates in the Healthcare sector within the Biotechnology industry.